J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okumura, Y.
Right arrow Articles by Nikai, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okumura, Y.
Right arrow Articles by Nikai, T.
Agricola
Right arrow Articles by Okumura, Y.
Right arrow Articles by Nikai, T.
J Med Microbiol 53 (2004), 351-354; DOI: 10.1099/jmm.0.05248-0
© 2004 Society for General Microbiology
ISSN 0022-2615

Elastase and elastase inhibitor from Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger

Yoshiyuki Okumura1,2, Kenji Ogawa3 and Toshiaki Nikai2

1Department of Quality Control, Mathuurayakugyo Co. Ltd, 24-21 Enjo-chou, Syowa-ku, Nagoya 466-0054, Japan 2Department of Microbiology, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tenpaku-ku, Nagoya 468-8503, Japan 3Department of Pulmonary Medicine, National Higashinagoya Hospital, 5-101 Umemorizaka, Meito-ku, Nagoya 465-8620, Japan

Correspondence Toshiaki Nikai nikai{at}ccmfs.meijo-u.ac.jp

Received March 10, 2003
Accepted December 19, 2003

Elastolytic and elastase inhibitory activities were investigated for 13 strains of Aspergillus fumigatus, three strains of Aspergillus flavus and three strains of Aspergillus niger. Nine of the 13 strains of A. fumigatus and all strains of A. flavus demonstrated elastase activity (more than 1 unit ml–1). Six of the 13 strains of A. fumigatus and all strains of A. flavus expressed elastase inhibitory activity (more than 2 units ml–1). However, no elastase or elastase inhibitory activities were observed with A. niger. It was also found that crude elastase inhibitors from six strains of A. fumigatus and two strains of A. flavus were stable to heat treatment at 100 °C for 10 min. In addition, human leukocyte elastases were inhibited by crude elastase inhibitors from A. fumigatus and A. flavus; however, no effect was observed on the elastase derived from porcine pancreas.


Abbreviation: STANA, succinyl-L-alanyl-L-alanyl-L-alanyl-p-nitroanilide.


    Introduction
 TOP
 Introduction
 Methods
 Results and Discussion
 ACKNOWLEDGEMENTS
 References
 
This laboratory has shown that elastolytic proteinases can be obtained from Aspergillus fumigatus and Aspergillus flavus (Hasegawa et al., 1995, 1997). It has been shown that elastases obtained from Aspergillus spp. (Frosco et al., 1992; Mellon & Cotty, 1995; Monod et al., 1991; Reichard et al., 1990; Rhodes et al., 1990) are pathogenic factors (Iadarola et al., 1998; Frosco et al., 1994; Kolattukudy et al., 1993; Denning et al., 1992).

Protease inhibitors have also been isolated from various sources in the past. For example, some trypsin inhibitors have been isolated from plants; {alpha}2-macroglobulin, antithrombin III and {alpha}1-antitrypsin have been obtained from serum; and leupeptin, antipain, chymostatin and pepstatin have been isolated from actinomycetes. In addition, elasnin (Ohno et al., 1980), elafin (Wiedow et al., 1990), elastatinal (Umezawa et al., 1973) and ONO-5046 (Kawabata et al., 1991) are reported as elastase inhibitors. Elastase inhibitors are inhibitors of leukocyte elastase and promote anti-inflammatory action. The elastase activity of Aspergillus spp. was investigated by the study of Aspergillus culture filtrates in which elastase activity was increased and/or decreased every 3 or 4 days. These results definitively show the presence of elastase inhibitor.

In the present study, the screening and some properties of elastase inhibitors from 13 strains of A. fumigatus, three strains of A. flavus and three strains of Aspergillus niger isolated from sputum samples are reported.


    Methods
 TOP
 Introduction
 Methods
 Results and Discussion
 ACKNOWLEDGEMENTS
 References
 
Elastase and elastase inhibitor from A. fumigatus, A. flavus and A. niger.

A. fumigatus, A. flavus and A. niger were identified and isolated from sputum. Elastase was obtained as follows. A sufficient number of fungal spores (A. fumigatus, A. flavus and A. niger) were cultured in 100 ml of a synthetic medium of 1 % yeast carbon base (Difco) containing 1 % elastin (Sigma) as a nitrogen source. The cultures were incubated at 37 °C with shaking at 100 r.p.m. for 12 days.

Elastase inhibitor was obtained by the following method. A sufficient number of fungal spores (A. fumigatus, A. flavus and A. niger) were cultured in 100 ml of synthetic medium of 1 % yeast carbon base containing 1 % Casamino acids (Difco) as a nitrogen source. The cultures were incubated at 37 °C for 7 days.

Assay for elastolytic activity.

Elastolytic activity of the crude enzyme was assayed by the method of diazocoupling and measuring the p-nitroanilide (p-NA) released from 50 mM succinyl-L-alanyl-L-alanyl-L-alanyl-p-nitroanilide (STANA) (Peptide Institute Inc., Osaka, Japan) in DMSO used as the substrate (Hasegawa et al., 1997). To determine the extent of STANA digestion, 0.1 ml of the enzyme solution, 0.9 ml of 50 mM Tris/HCl buffer, pH 7.5, and 20 µl of 50 mM STANA solution were incubated for 60 min at 37 °C. The reaction was stopped by adding 1 ml of 10 % trichloroacetic acid (TCA). Then, 0.2 ml of 0.1 % sodium nitrate, 0.5 % ammonium sulfamate and 0.1 % N-(1-naphthyl)ethylenediamine dihydrochloride were added to the solution and the colour that developed was read at 550 nm. One unit is defined as the amount of p-NA released from STANA at 1 min.

Assay for elastase inhibitory activity.

Fifty microlitres of elastase inhibitor solution (crude enzyme) was mixed with the purified elastase from A. flavus and incubated for 15 min at 37 °C prior to the addition of the STANA substrate. Then, 0.9 ml of 50 mM Tris/HCl buffer, pH 7.5, and 20 µl of 50 mM STANA solution were added and incubated for 60 min at 37 °C. The reaction was stopped by adding 1 ml of 10 % TCA. Then, 0.2 ml of 0.1 % sodium nitrate, 0.5 % ammonium sulfamate and 0.1 % N-(1-naphthyl)ethylenediamine dihydrochloride were added to the solution and the colour developed was read at 550 nm. One unit is defined as the minimal dose that did not release p-NA from STANA at 1 min.


    Results and Discussion
 TOP
 Introduction
 Methods
 Results and Discussion
 ACKNOWLEDGEMENTS
 References
 
Elastolytic activity.

Each day, 1 ml of the culture broth was filtered aseptically through a 0.22 µm pore-size membrane filter. The cell-free culture supernatant was used as the source of crude enzyme and the elastolytic activity of the culture supernatant was measured. Nine of the 13 strains of A. fumigatus demonstrated elastase activity (more than 1 unit ml–1). Data from six strains are shown in Fig. 1; these strains exhibited elastase inhibitory activity (more than 2 units ml–1). In addition, all strains of A. flavus demonstrated elastase activity (Fig. 2). However, no elastase activity was observed with A. niger.



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 1. Elastolytic activity of A. fumigatus strains. Solid lines: •, AFU-2; {blacktriangleup}, AFU-3; {blacksquare}, AFU-5. Broken lines: •, AFU-6; {blacktriangleup}, AFU-9; {blacksquare}, AFU-12.

 


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2. Elastolytic activity of A. flavus (AFL) and A. niger (AN) strains. Solid lines: •, AFL-1; {blacktriangleup}, AFL-2; {blacksquare}, AFL-3. Broken lines: •, AN-1; {blacktriangleup}, AN-2; {blacksquare}, AN-3.

 

Elastase inhibitory activity.

Each day, 1 ml of the culture broth was filtered aseptically through a 0.22 µm pore-size membrane filter. The cell-free culture supernatant was used as the source of crude enzyme and the elastase inhibitory activity of the culture supernatant was measured. Six of the 13 strains of A. fumigatus and two strains of A. flavus showed elastase inhibitory activity (Figs 3 and 4). A. niger was non-responsive as no inhibitory activity was detected.



View larger version (34K):
[in this window]
[in a new window]
 
Fig. 3. Elastase inhibitory activity of A. fumigatus strains. Solid lines: •, AFU-2; {blacktriangleup}, AFU-3; {blacksquare}, AFU-5. Broken lines: •, AFU-6; {blacktriangleup}, AFU-9; {blacksquare}, AFU-12.

 


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 4. Elastase inhibitory activity of A. flavus (AFL) and A. niger (AN) strains. Solid lines: •, AFL-1; {blacktriangleup}, AFL-2; {blacksquare}, AFL-3. Broken lines: •, AN-1; {blacktriangleup}, AN-2; {blacksquare}, AN-3.

 

Heat stability of elastase inhibitory activity of culture supernatant from A. fumigatus and A. flavus.

The culture supernatants were heated for 10 min at various temperatures (37, 50, 60, 80 and 100 °C), quickly cooled to 4 °C, and the elastase inhibitory activity on STANA was determined (Fig. 5). All culture supernatants were stable to heat treatment, with 60–95 % of the activity remaining even after heat treatment at 100 °C for 10 min (pH 5.5).



View larger version (14K):
[in this window]
[in a new window]
 
Fig. 5. Heat stability of culture supernatants of A. fumigatus (AFU) and A. flavus (AFL) strains. Solid lines: •, AFU-2; {blacktriangleup}, AFU-3; {blacksquare}, AFU-5; {bigcirc}, AFL-1; {triangleup}, AFL-2. Broken lines: •, AFU-6; {blacktriangleup}, AFU-9; {blacksquare}, AFU-12.

 

Elastases from pancreas and leukocytes were incubated for 15 min at 37 °C with elastase inhibitors. Following incubation, 0.9 ml of 50 mM Tris/HCl buffer, pH 7.5, and 20 µl of 50 mM STANA solution were added and incubated for an additional 60 min at 37 °C. The reaction was stopped by adding 1 ml of 10 % TCA followed by 0.2 ml of 0.1 % sodium nitrate, 0.5 % ammonium sulfamate and 0.1 % N-(1-naphthyl)ethylenediamine dihydrochloride. Colour was developed and read at 550 nm. Elastase from pancreas was inhibited 12.1, 11.1 and 6.5 % by A. fumigatus strains AFU-6, AFU-9 and AFU-12, respectively; it was not inhibited by A. fumigatus strains AFU-2, AFU-3 and AFU-5 nor by A. flavus strains AFL-1 and AFL-2. Elastase from leukocytes was inhibited 52.5, 36.8, 23.9, 33.6, 54.6, 27.4 and 15.0 % by A. fumigatus strains AFU-2, AFU-3, AFU-6, AFU-9 and AFU-12 and A. flavus strains AFL-1 and AFL-2, respectively; it was not inhibited by A. fumigatus strain AFU-5.

The purpose of this study was to develop a screening procedure and investigate the biological properties regarding elastase inhibitory activity of culture filtrates. Elastase activity (more than 1 unit ml–1) was recognized in nine strains of A. fumigatus and three strains of A. flavus. Elastase inhibitory activity (more than 2 units ml–1) was recognized in six strains of A. fumigatus and two strains of A. flavus, respectively. Since eight strains of Aspergillus demonstrated inhibitory activity against elastase, the possibility exists that the inhibitory activity is related to suppression of the immune system. The results indicate that the elastase inhibitor possesses resistance to the host defence and, as a consequence, could participate in the onset of mycosis. This could be caused by the elastase inhibitor not being susceptible to the host immune defence which would result in physiological conditions conducive to the occurrence of mycosis in the host.

These results also suggest that the activity of the crude elastase inhibitors from A. fumigatus and A. flavus on human leukocyte elastases may be helpful in the treatment of inflammation. More detailed investigations of the properties of the elastase inhibitor are needed in order to refine and purify the inhibitor and to investigate its relationship to mycosis as well as to test its effectiveness against inflammation caused by human leukocyte elastases.

It has been reported that Aspergillus-produced elastase is a definitive virulence factor of aspergillosis (Blanco et al., 2002). Frosco et al. (1992, 1994) and Kolattukudy et al. (1993) reported that elastase is a significant virulence factor to the extent that Frosco et al. (1994) used elastase-specific monoclonal and polyclonal antibodies. Kolattukudy et al. (1993) provided proof of virulence by using an elastase-producing and a non-producing strain (elastase-deficient mutant). Ogawa et al. (1992), Hasegawa et al. (1994) and Ogawa (1997) reported that urinastatin, which contains an enzyme inhibitor, was administered by way of intravenous drip infusion concomitantly with antifungal agents to patients suffering pulmonary aspergillosis. Maesaki et al. (1993) and Sugimura et al. (1994) reported urinastatin treatment of aspergillosis or aspergilloma. The results shown in Figs 1 and 2 confirm that the elastase inhibitor controls the action of elastase in releasing irritating and/or toxic products in vivo.

The results of this investigation indicate that the use of a highly purified and structurally determined elastase inhibitor would be more effective against aspergillosis than urinastatin.


    ACKNOWLEDGEMENTS
 TOP
 Introduction
 Methods
 Results and Discussion
 ACKNOWLEDGEMENTS
 References
 
We acknowledge the support of the Ministry of Education, Science, Sports and Culture (High-Tech Research Center Project). We are thankful to Akiko Hirofuzi for technical support.


    References
 TOP
 Introduction
 Methods
 Results and Discussion
 ACKNOWLEDGEMENTS
 References
 

  • Blanco, J. L., Hontecillas, R., Bouza, E., Blanco, I., Pelaez, T., Munoz, P., Perez Molina, J. & Garcia, M. E. (2002). Correlation between the elastase activity index and invasiveness of clinical isolates of Aspergillus fumigatus. J Clin Microbiol 40, 1811–1813.[Abstract/Free Full Text]

  • Denning, D. W., Ward, P. N., Fenelon, L. E. & Benbow, E. W. (1992). Lack of vessel wall elastolysis in human invasive pulmonary aspergillosis. Infect Immun 60, 5153–5156.[Abstract/Free Full Text]

  • Frosco, M. B., Chase, T., Jr & Macmillan, J. D. (1992). Purification and properties of elastase from Aspergillus fumigatus. Infect Immun 60, 728–734.[Abstract/Free Full Text]

  • Frosco, M. B., Chase, T., Jr & Macmillan, J. D. (1994). The effect of elastase-specific monoclonal and polyclonal antibodies on the virulence of Aspergillus fumigatus in immunocompromised mice. Mycopathologia 125, 65–76.[CrossRef][Medline]

  • Hasegawa, Y., Nikai, T., Yoshikawa, Y., Sugihara, H., Ogawa, K. & Takagi, K. (1994). Elastase activity from Aspergillus species and inhibition by urinastatin. Jpn J Med Mycol 35, 293–298.

  • Hasegawa, Y., Nikai, T., Yamashita, R., Yoshikawa, Y., Sugihara, H., Ogawa, K. & Mizuno, M. (1995). Isolation and characterization of elastolytic proteinase from Aspergillus fumigatus. Jpn J Med Mycol 36, 235–243.

  • Hasegawa, Y., Nikai, T., Okumura, Y., Ogawa, K. & Sugihara, H. (1997). Characterization of elastolytic proteinase from Aspergillus flavus: comparison of the elastolytic proteinase from Aspergillus fumigatus. Jpn J Med Mycol 38, 53–59.

  • Iadarola, P., Lungarella, G., Martorana, P. A. & 8 other authors (1998). Lung injury and degradation of extracellular matrix components by Aspergillus fumigatus serine proteinase. Exp Lung Res 24, 233–251.[Medline]

  • Kawabata, K., Suzuki, M., Sugitani, M., Imaki, K., Toda, M. & Miyamoto, T. (1991). ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun 177, 814–820.[CrossRef][Medline]

  • Kolattukudy, P. E., Lee, J. D., Rogers, L. M., Zimmerman, P., Ceselski, S., Fox, B., Stein, B. & Copelan, E. A. (1993). Evidence for possible involvement of an elastolytic serine protease in aspergillosis. Infect Immun 61, 2357–2368.[Abstract/Free Full Text]

  • Maesaki, S., Kohno, S., Tanaka, K. & 7 other authors (1993). A case of pulmonary aspergilloma successfully treated with combination therapy of intracavitary injection of amphotericin B and intravenous administration of urinastatin. Nihon Kyobu Shikkan Gakkai Zasshi 31, 1327–1331 (in Japanese).[Medline]

  • Mellon, J. E. & Cotty, P. J. (1995). Expression of elastinolytic activity among isolates in Aspergillus section flavi. Mycopathologia 131, 115–120.[CrossRef][Medline]

  • Monod, M., Togni, G., Rahalison, L. & Frenk, E. (1991). Isolation and characterization of an extracellular alkaline protease of Aspergillus fumigatus. J Med Microbiol 35, 23–28.[Abstract]

  • Ogawa, K. (1997). Treatment of chronic pulmonary aspergillosis (fungus ball type, mural thickness type). Kekkaku 72, 119–124 (in Japanese).[Medline]

  • Ogawa, K., Taki, F., Takagi, K., Furui, H., Tsuda, M., Honda, K., Sasaki, T., Sasamoto, M. & Miwa, T. (1992). Study of elastase production by Aspergillus species and inhibition of their elastase activity by drugs. Kokyuu 11, 880–886 (in Japanese).

  • Ohno, H., Yoshida, M., Takahashi, Y. & Omura, S. (1980). Improvement of the productivity of elasnin, a specific elastase inhibitor, by Streptomyces noboritoensis KM-2753. J Antibiot (Tokyo) 33, 474–479.[Medline]

  • Reichard, U., Buttner, S., Eiffert, H., Staib, F. & Ruchel, R. (1990). Purification and characterization of an extracellular serine proteinase from Aspergillus fumigatus and its detection in tissue. J Med Microbiol 33, 243–251.[Abstract]

  • Rhodes, J. C., Amlung, T. W. & Miller, M. S. (1990). Isolation and characterization of an elastinolytic proteinase from Aspergillus flavus. Infect Immun 58, 2529–2534.[Abstract/Free Full Text]

  • Sugimura, S., Yoshida, K., Oba, H., Hashiguchi, K., Nakajima, M., Moriya, O., Okimoto, N., Niki, Y. & Soejima, R. (1994). Two cases of invasive pulmonary aspergillosis in non-immunocompromised hosts. Nihon Kyobu Shikkan Gakkai Zasshi 32, 1032–1037 (in Japanese).[Medline]

  • Umezawa, H., Aoyagi, T., Okura, A., Morishima, H., Takeuchi, T. & Okami, Y. (1973). Letter: Elastatinal, a new elastase inhibitor produced by actinomycetes. J Antibiot (Tokyo) 26, 787–789.[Medline]

  • Wiedow, O., Schroder, J. M., Gregory, H., Young, J. A. & Christophers, E. (1990). Elafin: an elastase-specific inhibitor of human skin.Purification, characterization, and complete amino acid sequence. J Biol Chem 265, 14791–14795.[Abstract/Free Full Text]




    This article has been cited by other articles:


    Home page
    J Med MicrobiolHome page
    Y. Okumura, T. Matsui, K. Ogawa, K.-i. Uchiya, and T. Nikai
    Biochemical properties and primary structure of elastase inhibitor AFUEI from Aspergillus fumigatus
    J. Med. Microbiol., July 1, 2008; 57(7): 803 - 808.
    [Abstract] [Full Text] [PDF]


    This Article
    Right arrow Abstract Freely available
    Right arrow Full Text (PDF)
    Right arrow Alert me when this article is cited
    Right arrow Alert me if a correction is posted
    Right arrow Citation Map
    Services
    Right arrow Email this article to a friend
    Right arrow Similar articles in this journal
    Right arrow Similar articles in PubMed
    Right arrow Alert me to new issues of the journal
    Right arrow Download to citation manager
    Right arrow reprints & permissions
    Citing Articles
    Right arrow Citing Articles via HighWire
    Right arrow Citing Articles via CrossRef
    Right arrow Citing Articles via Google Scholar
    Google Scholar
    Right arrow Articles by Okumura, Y.
    Right arrow Articles by Nikai, T.
    Right arrow Search for Related Content
    PubMed
    Right arrow PubMed Citation
    Right arrow Articles by Okumura, Y.
    Right arrow Articles by Nikai, T.
    Agricola
    Right arrow Articles by Okumura, Y.
    Right arrow Articles by Nikai, T.


    HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
    INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS